Critical revision of the medical treatment of gout in Brazil

Valderilio Feijó Azevedo Maicon Piana Lopes Nathan Marostica Catholino Eduardo dos Santos Paiva Vitor Andrei Araújo Geraldo da Rocha Castelar Pinheiro About the authors

ABSTRACT

Gout is considered the most common form of inflammatory arthritis in men over 40 years. The authors present a brief review of the current treatment of gout and discuss the existing pharmacological limitations in Brazil for the treatment of this disease. Although allopurinol is still the main drug administered for decreasing serum levels of uric acid in gout patients in this country, the authors also present data that show a great opportunity for the Brazilian drug market for the treatment of hyperuricemia and gout and especially for patients using private and public (SUS) health care systems.

Keywords:
Gout; Hyperuricaemia; Treatment; Gouty arthritis; Medicines

Sociedade Brasileira de Reumatologia Av Brigadeiro Luiz Antonio, 2466 - Cj 93., 01402-000 São Paulo - SP, Tel./Fax: 55 11 3289 7165 - São Paulo - SP - Brazil
E-mail: sbre@terra.com.br